SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025338
Filing Date
2024-08-08
Accepted
2024-08-08 10:45:38
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q veru20240630_10q.htm   iXBRL 10-Q 1533078
2 EXHIBIT 31.1 ex_674186.htm EX-31.1 9060
3 EXHIBIT 31.2 ex_674187.htm EX-31.2 9090
4 EXHIBIT 32.1 ex_674188.htm EX-32.1 6218
  Complete submission text file 0001437749-24-025338.txt   8185714

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA veru-20240630.xsd EX-101.SCH 68597
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE veru-20240630_cal.xml EX-101.CAL 52373
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20240630_def.xml EX-101.DEF 472716
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240630_lab.xml EX-101.LAB 406939
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240630_pre.xml EX-101.PRE 505937
82 EXTRACTED XBRL INSTANCE DOCUMENT veru20240630_10q_htm.xml XML 1464913
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 241186745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)